Sbi Securities Co., Ltd. Neuro Sense Therapeutics Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 175 shares of NRSN stock, worth $204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175Holding current value
$204% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
10Shares Held
246KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$93,0050.01% of portfolio
-
Xtx Topco LTD London, X046KShares$53,8150.0% of portfolio
-
Meitav Dash Investments LTD40KShares$46,8000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$40,1070.0% of portfolio
-
Stratos Wealth Partners, Ltd.20KShares$23,4000.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $13.7M